在随后召开的2025北京."生命谷"医药数智化赋能生命健康之路研讨会上，与会专家聚焦"数智化赋能生 命健康"这一前沿议题，围绕人工智能助力公立医院高质量发展、AI重塑医药研发、计算医学驱动虚拟 临床试验等主题进行分享。高校、科研院所、行业协会、金融机构及企业代表参加活动。 新京报讯11月22日，以"智绘生命创领未来"为主题的生命谷(国际)生物工程创新中心启动大会暨2025北 京."生命谷"医药数智化赋能生命健康之路研讨会举行。中国卫生经济学会会长、国家卫生健康委财务 司原司长何锦国，昌平实验室党委副书记朱建红，区委书记、未来科学城党工委书记甘靖中，区委副书 记、区长，未来科学城党工委副书记、管委会主任刘晓东，北京农学院党委常委、副院长张劲柏出席。 据悉，生命谷(国际)生物工程创新中心是中国生命科学与未来产业前沿技术成果转化的战略首站，将聚 焦细胞与基因治疗、AI医疗等前沿赛道，锚定人工智能、电子信息、半导体等，形成"研发-中试-产业 化"全生命周期的生态闭环。这里汇聚全球顶尖科研资源与产业链上下游企业，依托国家级平台和临床 资源，将成为生物工程领域创新突破与成果转化的首选高地，为北京国际科技创新中心建设贡献" ...

Core Insights - The article highlights the journey of Zhu Jian, who transitioned from the TMT industry to the healthcare sector, founding Shulan Healthcare, which has become a technology-driven medical group redefining social healthcare possibilities [1][14]. Group 1: Company Development - Shulan Healthcare has evolved into a technology-driven medical group with a vision of inclusivity, leveraging computational medicine to innovate within the healthcare industry [1][12]. - The company has established a non-profit organization, the Open Medical and Healthcare Alliance (OMAHA), to promote medical data standardization and open sharing [5]. - Shulan Healthcare has developed a digital service ecosystem and launched the Aladdin user service system, achieving integrated online and offline services [5][10]. Group 2: Technological Innovations - The company has introduced the AI health assistant Dr. Shu, which has been rapidly implemented in hospitals, showcasing its role as a pioneer in the healthcare technology sector [2][6]. - Shulan Healthcare is focusing on the "All in Technology" strategy, aiming to reconstruct future medical models through computational medicine and develop AI future hospitals [6][12]. - The company is collaborating with various data intelligence firms to deepen its smart healthcare layout and promote the implementation of AI in future medical strategies [8][10]. Group 3: Educational Initiatives - Shulan Healthcare has partnered with Zhejiang Shuren University to establish the Shulan International Medical College, offering courses in computational medicine to cultivate talent in this emerging field [8][10]. - The establishment of the Zhejiang Province "Artificial Organs and Computational Medicine Key Laboratory" marks a significant milestone in the company's research and development efforts [13]. Group 4: Future Vision - The company aims to create a comprehensive health database that spans the entire lifecycle, providing dynamic data sources for digital twins [13][14]. - Shulan Healthcare envisions a future where AI and healthcare services are deeply integrated, enhancing accessibility and efficiency in medical care [14][15]. - The next decade will focus on advancing AI-driven healthcare solutions, with the ultimate goal of simulating life through computational medicine [12][14].

Core Insights - The article highlights the journey of Zhu Jian, who transitioned from the TMT industry to the healthcare sector, founding Shulan Healthcare, which has become a technology-driven medical group redefining social healthcare possibilities [1][2][3] Group 1: Company Development - Shulan Healthcare has evolved into a technology-driven medical group with a vision of inclusivity, leveraging computational medicine to innovate within the healthcare industry [1][4] - The company has developed the AI health assistant Dr.Shu, which has been successfully implemented in hospitals, showcasing its technological leadership in the medical field [2][6] - Shulan Healthcare has established a non-profit organization, OMAHA, to promote medical data standardization and open sharing, and launched an international multidisciplinary collaborative diagnosis platform [5][10] Group 2: Technological Integration - The concept of computational medicine, which views the human body as a complex integrated system, has significantly influenced Shulan Healthcare's development [4][9] - The company is focusing on AI-driven healthcare solutions, with plans to develop the Liangzhu Medical Center into an AI future hospital by 2026 [7][12] - Shulan Healthcare is building a comprehensive health database that integrates various health records, supporting the development of personal digital twins for enhanced patient care [14][15] Group 3: Future Vision - The company aims to leverage AI and computational medicine to create a new healthcare paradigm, emphasizing the importance of technology in enhancing healthcare accessibility and efficiency [11][13] - Shulan Healthcare's strategic upgrade to "All in Technology" reflects its commitment to advancing AI in healthcare and establishing a new model for medical services [13][16] - The next decade will focus on deepening the integration of AI and healthcare services, aiming to transform the industry and improve public health outcomes [15][18]

Core Viewpoint - Shulan Medical Group has officially launched its self-developed AI health assistant Dr.Shu, which integrates a comprehensive range of medical services covering pre-diagnosis, diagnosis, and post-diagnosis care [1] Group 1: Product Features - Dr.Shu includes an innovative "health steward" module that continuously tracks user health data to generate personalized health management plans [1] - The AI health assistant represents a significant advancement in the field of computational medicine, which is seen as a systematic and mechanism-driven paradigm of precision medicine [1] Group 2: Strategic Vision - The founder and president of Shulan Medical, Zheng Jie, emphasized that the development of Dr.Shu aligns with the company's "dual-driven" strategy and promotes the advancement of computational medicine [1] - Computational medicine is described as more than just a simple combination of traditional AI medical tools; it encompasses multi-scale life mechanism modeling, statistical learning, supercomputing, and medical knowledge engineering [1] Group 3: Future Goals - The ultimate goal of computational medicine is to achieve "life simulation," with one of the prerequisites being the facilitation of medical data circulation [1]

Group 1: Economic and Policy Updates - The Federal Reserve has maintained the federal funds rate at 4.25% to 4.50% for the fifth consecutive time, reflecting a cautious approach amid economic uncertainties and inflation risks [2] - The Chinese government is set to open applications for childcare subsidies in late August, with a comprehensive rollout expected by August 31 [3] Group 2: Corporate News - Aikang Group has filed a lawsuit against an individual questioning the company's cancer risk assessment practices, emphasizing the importance of trust in the health examination industry [6][7] - McDonald's plans to sell all its properties in Hong Kong, with an estimated market value of nearly 3 billion HKD, while restaurant operations will remain unaffected [20] Group 3: Industry Insights - NVIDIA's CEO predicts that the number of millionaires created in the AI sector over the next five years will surpass those created in the internet sector over the past 20 years, highlighting AI's potential as a significant equalizer in technology [16] - TreeLan Medical has launched an AI health assistant, aiming to advance the field of computational medicine and achieve the ultimate goal of "life simulation" [18]

Group 1 - The core viewpoint of the articles revolves around the advancements in AI technology within the healthcare sector, particularly through the initiatives of Shulan Medical, which has launched its AI health assistant, Dr. Shu, and is actively pursuing a strategy focused on computational medicine [2][10][19] - Shulan Medical has established strategic partnerships with various data intelligence companies to enhance its smart healthcare initiatives and implement its AI future medical strategy [2][10] - The founder and president of Shulan Medical, Zheng Jie, emphasizes the importance of computational medicine as a systematic and mechanism-driven paradigm for precision healthcare, which integrates multiple disciplines including statistical learning and AI technology [2][4][19] Group 2 - The concept of computational medicine is gaining traction globally, with initiatives like the EU's virtual human twin database and the NIH's Bridge2AI project in the US, which focus on multi-modal data construction to support precision medicine [3][4] - Shulan Medical's roadmap for computational medicine includes steps from data standardization to life modeling, aiming to create a patient-centered digital twin for personalized medical decision-making [3][4][5] - The development of electronic medical records (EMR), electronic health records (EHR), and personal health records (PHR) is crucial for building a comprehensive data foundation for computational medicine [5][6] Group 3 - The Open Medical and Healthcare Alliance (OMAHA), founded by Zheng Jie, aims to promote machine-readable standards for healthcare data, which is essential for achieving data interoperability and supporting the development of computational medicine [6][7] - OMAHA has introduced the HiTA technology stack, which enhances the interoperability of medical data and provides a high-quality standardized data foundation for personal health databases [7][10] - The transition from static data to dynamic data is highlighted through the development of personal digital twins (PDT), which aim to closely replicate human life through comprehensive information modeling [7][10] Group 4 - The rapid development of medical AI has led to its integration into various healthcare applications, with a focus on improving hospital operational efficiency, patient services, and research capabilities [10][11] - Shulan Medical's AI health assistant, Dr. Shu, is designed to enhance patient interaction and streamline the healthcare process by providing pre-diagnosis, diagnosis assistance, and post-treatment follow-up [12][13] - The digital twin concept is being explored to provide remote medical services, allowing for more personalized and efficient healthcare delivery [12][14] Group 5 - Shulan Medical's "All in Technology" strategy aims to reconstruct future healthcare models through computational medicine, integrating AI and wearable technologies to offer comprehensive health services [17][19] - The upcoming AI Future Health Medical Center is set to combine various healthcare technologies to create a seamless health service experience for users [18][19] - The focus on building a feedback loop between AI healthcare capabilities and real-world data is essential for enhancing the accuracy and accessibility of AI-driven medical services [18][19]

Group 1 - The core viewpoint of the articles emphasizes the transformative potential of "Artificial Intelligence+" in reshaping innovation paradigms and fostering a new era of human-machine-environment collaboration [1][2][3] - Experts highlight that "Artificial Intelligence+" is shifting from replacing physical labor to augmenting intellectual labor, fundamentally changing production, lifestyle, and learning methods [1][2] - The development of AI technologies, such as AlphaFold, demonstrates the capability of AI in scientific research, enabling precise predictions and data-driven methodologies [1] Group 2 - The integration of human, machine, and environmental systems is identified as the future direction for AI development, with a focus on leveraging human strategic planning alongside machine computational power [2] - In the medical field, "Artificial Intelligence+" is being redefined to enhance biopharmaceutical competitiveness through a system-oriented approach, emphasizing the potential of computational medicine [2] - The acceleration of foundational AI models is leading to a concentration among major platform companies, while startups are focusing on vertical applications, indicating a trend towards specialization in AI development [3]

Core Insights - The understanding of aging is evolving from a linear perspective to a dynamic interplay of genetics, lifestyle, and environmental exposure, with significant individual differences in organ age among peers [1] - The market is shifting from vague concepts of overall youthfulness to targeted organ-specific care, addressing core pain points such as liver detoxification, collagen loss in skin, and testosterone decline in men [2] Group 1: Company Innovations - LAIFE, a Boston-based life sciences AI formulation brand, is leveraging AI technology to decode the molecular mechanisms of organ aging, transitioning from "experience medicine" to "computational medicine" [2][3] - The RevOrgan AI formulation platform developed by LAIFE utilizes deep learning algorithms and organ aging models to create dynamic formulations, significantly reducing R&D time and enhancing product efficacy and stability [3][5] Group 2: Product Development - LAIFE has established a product matrix that includes various targeted formulations such as LAIFE "乐净肺" for lung health, LAIFE "乐轻肝" for liver support, and LAIFE "红宝瓶II" for ovarian health, addressing aging from multiple dimensions [5] - The AI system employed by LAIFE can dynamically simulate metabolic responses in organs, allowing for precise selection and optimization of ingredients through high-performance computing [5] Group 3: Research and Development - LAIFE's research foundation is supported by its parent company, RegenerativeBio, which integrates AI with biotechnology to enhance product precision and effectiveness [7] - The team at RegenerativeBio includes top scientists from prestigious institutions, ensuring rigorous testing and validation of LAIFE's products to meet international standards [7] Group 4: Future of Aging Science - LAIFE is pioneering a new paradigm in aging science, transforming aging from an inevitable fate into a decodable and potentially reversible process, enabled by advanced AI computational capabilities [9] - The company is actively promoting the integration of AI in aging research, hosting conferences and supporting academic initiatives to advance the field [7][9]

Core Insights - The rapid development of generative AI is profoundly reshaping the healthcare industry landscape by enabling predictive health management throughout an individual's life cycle [1] - Shulan Medical Group aims to integrate healthcare services, medical research, and education into a technology-driven medical group [1][3] - The founder, Zheng Jie, emphasizes the importance of technology in healthcare, having a background in computer science and a strong influence from early internet developments [2][3] Company Development - Over the past decade, Shulan Medical has successfully established itself as a leading private healthcare provider, creating a comprehensive ecosystem that includes medical services, education, and research [4] - The concept of "computational medicine" has significantly influenced the company's development, focusing on the integration of data-driven research and AI methodologies [5][6] Technological Integration - Shulan Medical is actively applying computational medicine techniques in clinical practices, aiming to enhance surgical success rates and patient safety through precise calculations [6] - The company plans to develop a comprehensive health management system that integrates multi-omics data, clinical data, and wearable device data [6] AI and Future Outlook - The company has launched an AI health assistant, Dr. Shu, which streamlines patient interactions and enhances healthcare management efficiency [8][9] - Zheng Jie envisions AI as a foundational element in the healthcare sector, aiming to provide comprehensive services from prevention to recovery through digital platforms [10] - Shulan Medical is committed to continuous innovation and investment in early-stage life science projects to maintain competitiveness in the healthcare market [10]

Core Viewpoint - The article discusses the unprecedented challenges and opportunities faced by China's private healthcare sector, highlighting Shulan Healthcare's innovative approach to integrating technology and medical services under the leadership of its founder, Zheng Jie [1][3]. Group 1: Company Overview - Shulan Healthcare is a technology-driven medical group that combines health services, medical research, and education, aiming to create a Chinese brand similar to the Mayo Clinic [3][4]. - The company operates under a "dual-wheel drive" strategy, focusing on both clinical medical services and life sciences research [3][4]. Group 2: Innovative Concepts - The concept of "computational medicine" is being implemented at Shulan Healthcare, which involves modeling life for more precise and personalized medical care [4][5]. - The establishment of the "Key Laboratory of Artificial Organs and Computational Medicine" in collaboration with Zhejiang Shuren University marks a significant milestone in the field of computational medicine [4]. Group 3: Strategic Development - Shulan Healthcare has developed a "dual-curve strategy" that balances core healthcare services with technological innovation and industrial transformation [6][7]. - The company emphasizes the importance of long-term health management relationships beyond traditional medical services [6][7]. Group 4: Future Vision - Zheng Jie envisions the construction of a new type of international medical center, integrating smart and digital elements to create a model for future hospitals [8][9]. - The focus on digitalization and smart healthcare services is expected to reshape the organization and delivery of medical services in the AI era [9][10]. Group 5: Social Responsibility - Shulan Healthcare actively engages in social responsibility initiatives, aligning with national policies to enhance public health through various hospitals and community activities [9][10]. - The Open Medical and Healthcare Alliance (OMAHA) was initiated by Zheng Jie to foster collaboration and standardization in the healthcare industry [9][10].